Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Summary

Ciprofloxacin PulmoSphere Inhalation Powder appears to be an effective and adequate antibiotic treatment for cystic fibrosis patients with P. aeruginosa colonisation. This planned study is the first study on the use of this new Ciprofloxacin PulmoSphere Inhalation Powder in the pediatric population of 6 to 12 years of age.

Timeline

Start

2009-07

Primary completion

2010-10

Completion

2010-10

Drugs

Indications